本文選題：宮頸癌 + 放療敏感性　； 參考：《復旦大學》2014年博士論文

【摘要】：目的：1.eIF-4A1、eIF-4E、eIF-4G1在宮頸癌的表達及臨床意義；2.調控eIF-4A1表達對宮頸癌Siha、Hela細胞功能的影響；3.eIF-4A1對宮頸癌放療敏感性的影響及機制。材料和方法：35例正常宮頸組織及137例宮頸癌患者的石蠟標本均來源于復旦大學附屬腫瘤醫(yī)院組織庫。采用Siha、Hela細胞做為載體進行體外體內實驗。實驗方法包括CCK8試劑盒檢測細胞增殖實驗,Transwell檢測細胞的遷移侵襲能力,流式細胞儀檢測細胞凋亡和周期,克隆形成實驗檢測細胞的放療敏感性,以及裸鼠皮下成瘤和放療相關實驗。Western blot實驗進行相關的機制研究。結果：1.eIF-4A1、eIF-4E 和 eIF-4G1在正常宮頸組織中表達陰性,宮頸癌中高表達(陽性率大于80%)。eIF-4A1、eIF-4 E 和 eIF-4G1表達水平與患者的FIGO分期、組織病理學類型、盆腔淋巴結有無轉移相關(P0.05)。放療后eIF-4A1和eIF-4E表達變化和患者的放療敏感性相關(P分別為0.029、0.012)。放療后eIF-4A1表達降低的患者預后較好(P=0.002),并且是患者良好預后的獨立影響因素(P=0.047)。2.抑制eIF-4A1表達可以抑制宮頸癌細胞的增殖、侵襲轉移,促進細胞凋亡,延遲細胞放療所致DSB損傷修復。3.體內體外實驗證實,降低eIF-4A1表達可以增加宮頸癌的放療敏感性。結論：放療后eIF-4A1表達下降是宮頸癌良好預后的獨立影響因素。eIF-4A1通過延遲放療后DSB損傷修復增加宮頸癌的放療敏感性。
[Abstract]:Objective to investigate the expression and clinical significance of eIF-4A1EIF-4EIF-4G1 in cervical carcinoma. Regulation of eIF-4A1 expression on the function of Siha-Hela cells in Cervical Cancer. 3. The effect of eIF-4A1 on the radiosensitivity of cervical cancer and its mechanism. Materials and methods paraffin specimens of 35 normal cervical tissues and 137 cervical cancer patients were collected from the tissue bank of tumor Hospital affiliated to Fudan University. Sihagne Hela cells were used as carriers for in vitro experiments. The methods included CCK8 kit and Transwell assay, flow cytometry to detect cell apoptosis and cell cycle, clone formation assay to detect the sensitivity of cell to radiotherapy, to detect cell migration and invasion ability, to detect cell apoptosis and cell cycle by flow cytometry. The mechanism of subcutaneous tumorigenesis and radiotherapy-related experiments in nude mice was studied by Western blot assay. Results 1. The expression of eIF-4A1eIF-4E and eIF-4G1 were negative in normal cervix, and the overexpression of eIF-4A1eIF-4E and eIF-4G1 in cervical carcinoma were correlated with Figo stage, histopathological type and pelvic lymph node metastasis (P0.05). The changes of eIF-4A1 and eIF-4E expression were correlated with the radiosensitivity of patients after radiotherapy (P = 0.029, 0.012, respectively). The patients with lower expression of eIF-4A1 after radiotherapy had a better prognosis (P0. 002) and were independent factors of good prognosis (P0. 047). 2. Inhibiting the expression of eIF-4A1 can inhibit the proliferation, invasion and metastasis of cervical cancer cells, promote apoptosis and delay the repair of DSB damage induced by radiotherapy. In vivo and in vitro experiments have shown that reducing the expression of eIF-4A1 can increase the radiosensitivity of cervical cancer. Conclusion: the decrease of eIF-4A1 expression after radiotherapy is an independent factor influencing the good prognosis of cervical cancer. EIF-4A1 increases the radiosensitivity of cervical cancer through DSB damage repair after delayed radiotherapy.
【學位授予單位】：復旦大學
【學位級別】：博士
【學位授予年份】：2014
【分類號】：R737.33

【參考文獻】

相關期刊論文 前2條

1 莊亮;于世英;黃曉園;曹陽;熊慧華;;DNA-PKcs、Ku80及ATM備選宮頸癌放療增敏靶點的體外研究[J];癌癥;2007年07期

2 潘保見;陳嘉薇;祝峰;;宮頸鱗癌和癌前病變中eIF-4E表達及其與HPV16/18感染的關系[J];臨床與實驗病理學雜志;2007年05期

，

本文編號：2096352